Management Team

Vision, Creativity and Experience

Eyal Wachtenberg, Founder and Active Chairman of the Board
Eyal, the inventor of QuiCare's technologies, brings decades of experience in high level industrial and technology management. Concurrently with his role as Chairman of the Board, he also serves as CEO of Exerra Ltd., a company involved in the design of X-Ray machine vision inspection for the electronics assembly industry. Eyal has held several leadership positions in Israel's high-tech industry, including Managing Director of Business Development at Zinook, a start-up accelerator and Telecom and Internet Business Development Manager at Microsoft Israel, where he was in charge of funding and business development for more than 20 early-stage technology companies. Eyal has a BSc in Mechanical Engineering from the Technion, Israel Institute of Technology, and an MBA from The Leon Recanati Graduate School of Business Administration at Tel Aviv University.

Nissim Greisas, Founder and COO
As Chief Operating Officer of QuiCare, Nissim is responsible for general management, product development, financing and marketing and sales activities. He has more than 25 years of accumulated experience in these areas, having established and managed g.n.Initiative, a consulting firm specializing in strategic planning, business development and capital investment management of technology-oriented firms, and as Global Marketing Manager for Degem Systems and Business Development and Marketing Manager for Telrad Networks. Nissim has a BSc in Electronic Engineering from SUNY Buffalo, US, and an MBA from The Leon Recanati Graduate School of Business Administration at Tel Aviv University.

Dan Eylon, Ph.D., VP Research and Development
As VP Research and Development, Dan is responsible for QuiCare product development, patenting and regulatory applications. He has 18 years of experience in R&D management, in both established companies and startup environments. In 1994, Dan joined Nova Measuring Instruments (NASDAQ:NVMI) in its early stages and served as manager of the Software and Algorithms disciplines. Subsequently, he served as VP R&D for two startup companies involved in digital printing and communications. In 2000, Dan joined AppStream, a startup developing novel technologies for streaming software, and as VP R&D, was responsible for transferring R&D activities from Israel to the US. Dan appears as inventor on 11 patents invented during his work to date. He has a BSc in Physics and Mathematics from the Hebrew University of Jerusalem, and MSc and PhD in Medical Physics from Tel-Aviv University.

Edward R. Siemens, Chief Marketing Officer
Ed is responsible for US field sales, service, marketing, corporate accounts, clinical education, sales order support and customer support operations. He has extensive experience in the consumer and professional healthcare market sectors, having served as VP Sales and Marketing, and later President of Omron Healthcare Inc, the world’s largest global manufacturer of home-use digital blood pressure monitors and medical diagnostic products, and VP Sales of the Home Healthcare Division at McKesson Corporation, the leading US distributor of healthcare products to pharmacies and home medical equipment dealers. In this capacity, he directed all sales functions through 48 distribution centers nationwide serving over 22,000 customers and generating over $160 million in revenues. Ed has an MBA from Pepperdine University, Malibu, California

Advisory Board

QuiCare’s management team is supported by a Board of Directors and a strong scientific advisory board consisting of top global experts, opinion leaders and physicians well known and respected for their education, clinical expertise, research and publications in the field of blood pressure and hypertension.

Professor Giuseppe Mancia, MD
Professor Mancia is Professor of Medicine and Chairman of the Department of Clinical Medicine, Prevention and Applied Biotechnologies of the University of Milan-Bicocca, Italy. He is President of the European Society of Hypertension (ESH), and a past president of the International Society of Hypertension (ISH), the European Society of Clinical Investigation and the Italian Society of Hypertension. He has served/serves as a member of the editorial board of more than 30 international journals, and is currently deputy editor of the Journal of Hypertension. Professor Mancia has lectured at over 150 international meetings, edited several books on hypertension, and published more than 700 original papers, reviews and editorials.

Professor Talma Rosental, MD
Professor Rosenthal is an internationally-acclaimed specialist in the area of hypertension. Head of the Hypertension Unit at the Chaim Sheba Medical Center, Tel Hashomer, Israel, since 1974, she has been the incumbent of the Hella Gertner Chair for hypertension research in Tel Aviv University since 2000. Professor Rosental is an active member of the International Society of Hypertension, the Israel Society of Hypertension, the American Society of Hypertension, and the Council for High Blood Pressure Research of the American Heart Association. She is currently on the editorial board of various hypertension journals, and has published more than 250 publications and more than 150 papers.

Professor Meir Nitzan
Professor Nitzan serves as a Professor of Physics in the Department of Applied Physics/Electro-Optics and Biomedical Engineering in the Jerusalem College of Technology (JCT) and is also a member of the Israeli Council for Higher Education. He has been involved in the development of several innovative medical devices related to the assessment of the cardiovascular system, including a novel, non-invasive method for the automatic measurement of blood pressure, which was commercialized in a start-up company, Ninbar. Professor Nitzan has published more than 50 publications, presented papers at more than 70 international conferences and has 11 international patents, including patents related to the development of devices for arterial blood pressure measurement.

Company Profile

Incorporated in 2003, QuiCare is a privately-funded, early-stage company developing low-cost healthcare devices and providing services for measuring, processing and transmitting vital human diagnostic data that monitors and improves individual life expectancy and well being. Converging with the move of patients and clinicians from reactive to proactive models of healthcare delivery that facilitate home and self-care solutions, QuiCare solutions enable people to play a greater role in maintaining their own health.

QuiCare’s innovative solutions are based on a disruptive technology which offers a new, convenient and effective way for high blood pressure (hypertension) detection, transient hypertension monitoring and vital life assessment in multiple non-clinical, clinical and emergency settings. The Company recently unveiled Press-O-Sense, the first-ever disposable, automatic blood pressure monitoring device "on-a-chip". Addressing a problem affecting close to 1 billion people worldwide, it offers a cost-effective opportunity to move blood pressure testing from the clinic to the comfort of home.

QuiCare plans to take advantage of the growing demand for preventive care testing and leverage its unique intellectual property and first-to-market entry to build a strong market position. Employing a team of dedicated and experienced interdisciplinary professionals for R&D and highly experienced management and marketing teams, the Company is further bolstered by an Advisory Board consisting of internationally-acclaimed business, academic and clinical professionals.